SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.87%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$213M
AUM Growth
+$213M
(+27%)
Cap. Flow
+$38.9M
Cap. Flow
% of AUM
18.3%
Top 10 Holdings %
Top 10 Hldgs %
45.19%
Holding
183
New
52
Increased
11
Reduced
18
Closed
46
Top Buys
| 1 |
Tenax Therapeutics
TENX
|
$11.8M |
| 2 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$8.78M |
| 3 |
Opko Health
OPK
|
$7.75M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$6.23M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$6.02M |
Top Sells
| 1 |
MannKind Corp
MNKD
|
$20.5M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$5.37M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.79M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$4.6M |
| 5 |
Arbutus Biopharma
ABUS
|
$4.14M |
Sector Composition
| 1 | Healthcare | 87.73% |
| 2 | Energy | 1.29% |
| 3 | Communication Services | 0% |
| 4 | Materials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $19.3M | 1.08% | 364,741 -101,571 | -22% | -$5.37M |
|
|
2
Tenax Therapeutics
TENX
$27.3M
| $11.8M | 0.66% | +2,120,754 | New | +$11.8M |
|
3
Acadia Pharmaceuticals
ACAD
$4.38B
| $11.3M | 0.63% | 463,146 -93,867 | -17% | -$2.28M |
|
4
Gilead Sciences
GILD
$140B
| $11M | 0.62% | 155,073 +77,073 | +99% | +$5.46M |
|
|
BPTH
5
DELISTED
Bio-Path Holdings Inc
BPTH
| $8.78M | 0.49% | +3,313,600 | New | +$8.78M |
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $8.46M | 0.47% | 352,100 -155,600 | -31% | -$3.74M |
|
|
7
Opko Health
OPK
$1.1B
| $7.75M | 0.43% | +831,237 | New | +$7.75M |
|
|
8
SPDR S&P Biotech ETF
XBI
$5.07B
| $6.23M | 0.35% | +43,745 | New | +$6.23M |
|
|
CDMO
9
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $6.02M | 0.34% | +238,409 | New | +$6.02M |
|
10
uniQure
QURE
$896M
| $5.51M | 0.31% | +354,000 | New | +$5.51M |
|
11
Amgen
AMGN
$155B
| $5.22M | 0.29% | +42,311 | New | +$5.22M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.16M | 0.29% | +17,191 | New | +$5.16M |
|
|
CEMP
13
DELISTED
Cempra, Inc.
CEMP
| $4.69M | 0.26% | 405,946 +168,946 | +71% | +$1.95M |
|
14
Thermo Fisher Scientific
TMO
$186B
| $4.65M | 0.26% | +38,630 | New | +$4.65M |
|
|
AKTX
15
Akari Therapeutics
AKTX
$24.8M
| $4.34M | 0.24% | +669,080 | New | +$4.34M |
|
|
BLRX
16
BioLineRX
BLRX
$16.2M
| $4.24M | 0.24% | +1,902,800 | New | +$4.24M |
|
17
MacroGenics
MGNX
$112M
| $4.19M | 0.23% | +150,553 | New | +$4.19M |
|
|
ALIM
18
DELISTED
Alimera Sciences, Inc.
ALIM
| $3.95M | 0.22% | +500,000 | New | +$3.95M |
|
|
EPZM
19
DELISTED
Epizyme, Inc
EPZM
| $3.44M | 0.19% | +151,220 | New | +$3.44M |
|
20
Sangamo Therapeutics
SGMO
$157M
| $3.21M | 0.18% | +177,265 | New | +$3.21M |
|
21
Tempest Therapeutics
TPST
$44M
| $3.2M | 0.18% | 357,354 +205,018 | +135% | +$1.83M |
|
|
TSRO
22
DELISTED
TESARO, Inc.
TSRO
| $2.9M | 0.16% | +98,500 | New | +$2.9M |
|
23
Tonix Pharmaceuticals
TNXP
$260M
| $2.86M | 0.16% | +275,000 | New | +$2.86M |
|
|
KERX
24
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.86M | 0.16% | +167,999 | New | +$2.86M |
|
|
RXDX
25
DELISTED
Ignyta, Inc.
RXDX
| $2.84M | 0.16% | +341,810 | New | +$2.84M |
|